Pathology and bio markers of prostate cancer
Publication
, Journal Article
Sakr, WA; Brawer, MK; Moul, JW; Donohue, R; Schulman, CG
Published in: Prostate Cancer and Prostatic Diseases
1999
This session included five presentations in the areas of pathology of precursor lesions and carcinoma of the prostate, the value of determining neovascularity in the diagnosis and staging of prostate cancer, new 'molecular' markers, correlation between pre- and postoperative Gleason scores and a study dealing with transition zone PSA density. The abstracts and talks are summarized in the next few pages. © 1999 Stockton Press All rights reserved.
Duke Scholars
Published In
Prostate Cancer and Prostatic Diseases
Publication Date
1999
Volume
2
Issue
3331
Start / End Page
7 / 14
Related Subject Headings
- Urology & Nephrology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Sakr, W. A., Brawer, M. K., Moul, J. W., Donohue, R., & Schulman, C. G. (1999). Pathology and bio markers of prostate cancer. Prostate Cancer and Prostatic Diseases, 2(3331), 7–14.
Sakr, W. A., M. K. Brawer, J. W. Moul, R. Donohue, and C. G. Schulman. “Pathology and bio markers of prostate cancer.” Prostate Cancer and Prostatic Diseases 2, no. 3331 (1999): 7–14.
Sakr WA, Brawer MK, Moul JW, Donohue R, Schulman CG. Pathology and bio markers of prostate cancer. Prostate Cancer and Prostatic Diseases. 1999;2(3331):7–14.
Sakr, W. A., et al. “Pathology and bio markers of prostate cancer.” Prostate Cancer and Prostatic Diseases, vol. 2, no. 3331, 1999, pp. 7–14.
Sakr WA, Brawer MK, Moul JW, Donohue R, Schulman CG. Pathology and bio markers of prostate cancer. Prostate Cancer and Prostatic Diseases. 1999;2(3331):7–14.
Published In
Prostate Cancer and Prostatic Diseases
Publication Date
1999
Volume
2
Issue
3331
Start / End Page
7 / 14
Related Subject Headings
- Urology & Nephrology
- 1112 Oncology and Carcinogenesis